Literature DB >> 22560234

Predictors of emergency department death for patients presenting with ruptured abdominal aortic aneurysms.

Matthew W Mell1, Rachael A Callcut, Fritz Bech, M Kit Delgado, Kristan Staudenmayer, David A Spain, Tina Hernandez-Boussard.   

Abstract

OBJECTIVE: Ruptured abdominal aortic aneurysm (rAAA) is a critically time-sensitive condition with outcomes dependent on rapid diagnosis and definitive treatment. Emergency department (ED) death reflects the hemodynamic stability of the patient upon arrival and the ability to mobilize resources before hemodynamic stability is lost. The goals of this study were to determine the incidence and predictors of ED death for patients presenting to EDs with rAAAs.
METHODS: Data for patients presenting with International Classification of Disease, 9th Revision, Clinical Modification codes for rAAA from 2006 to 2008 were extracted from discharge data using the Nationwide Emergency Department Sample (NEDS), Healthcare Cost and Utilization Project, and Agency for Healthcare Research and Quality. The NEDS is the largest stratified weighted sample of US hospital-based ED visits with links to inpatient files. We compared those transferred to those admitted and treated. Sample weights were applied to produce nationally representative estimates. Patient and hospital factors associated with transfer were identified using multivariate logistic regression. These factors were then analyzed for a relationship with ED deaths.
RESULTS: A total of 18,363 patients were evaluated for rAAAs. Of these, 7% (1201) died in the ED, 6% (1160) were admitted and died without a procedure, 42% (7731) were admitted and died after repair, and 41% (7479) were admitted, treated, and survived. Transfers accounted for 4% (793) of all ED visits for rAAAs. ED death was more likely for patients seen in nonmetropolitan hospitals (12.7%) vs metropolitan nonteaching (7.0%) or metropolitan teaching hospitals (4.5%; P < .0001). Compared with other regions, the West had a higher ED mortality rate (9.6% vs 5.1%-6.9%; P = .0038). On multivariate analysis, ED death was associated with hospital groups exhibiting both high and low transfer rates.
CONCLUSIONS: ED death remains a significant cause for mortality for rAAAs and varies by hospital type, rural/urban location, and geographic region. Both delays in ED arrival and delays in providing definitive care may contribute to increased ED death rates, suggesting that improved regional systems of care may improve survival after rAAA.
Copyright © 2012 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22560234     DOI: 10.1016/j.jvs.2012.02.025

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  4 in total

1.  Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.

Authors:  Hui-fang Zhou; Huimin Yan; Paula Bertram; Ying Hu; Luke E Springer; Robert W Thompson; John A Curci; Dennis E Hourcade; Christine T N Pham
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

2.  A propensity score-matching analysis of transthoracic echocardiography and abdominal ultrasonography for the detection of abdominal aortic aneurysms.

Authors:  Takao Kato; Seiko Ishida; Shoichi Miyamoto; Tamae Iura; Yoko Ban; Jun Fujikawa; Eisaku Nakane; Toshiaki Izumi; Tetsuya Haruna; Koji Ueyama; Ryuji Nohara; Moriaki Inoko
Journal:  Clin Med Insights Cardiol       Date:  2015-03-19

3.  Ruptured Abdominal Aortic Aneurysm Treated by Double-Balloon Technique and Endovascular Strategy: Case Series.

Authors:  Hiroyuki Nakayama; Masanao Toma; Taishi Kobayashi; Nobuhisa Ohno; Tatsuji Okada; Go Ueno; Yukihito Sato
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-03-01       Impact factor: 1.520

4.  Improving the outcomes from ruptured abdominal aortic aneurysm: interdisciplinary best practice guidelines.

Authors:  R J Hinchliffe; J T Powell
Journal:  Ann R Coll Surg Engl       Date:  2013-03       Impact factor: 1.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.